Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
Biocon Limited is an India-based biopharmaceutical company, engaged in the manufacture of biotechnology products and research services. The Company is in the business of manufacturing active ...
https://www.thehindubusinessline.com/markets/stock-markets/biocon-shares-decline-despite-analyst-optimism-on-biologics-merger-deal/article70371607.ece Copy Biocon ...
The Indian pharmaceutical sector is witnessing a period of steady growth as top firms report their latest financial results, leading analysts at Nuvama to issue optimistic outlooks for several key ...
Diabetes pen market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 8.95% in the above ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results